DUSP6 and acute myeloid leukemia: Another study identified the increased expression of DUSP6 as a key factor in the progression of secondary acute myeloid leukaemia (sAML) by promoting JAK-STAT and ERK signalling, inflammatory cytokine production, and resistance to JAK2 inhibitors.